OGT knockdown counteracts high phosphate-induced vascular calcification in chronic kidney disease through autophagy

Tian-Hua Xu1, Zitong Sheng1, Yue Li1

  • 1Department of Nephrology, the First Hospital of China Medical University, Shenyang 110001, PR China.

Life Sciences
|July 22, 2020
PubMed
Abstract

Insights

O-GlcNAc transferase (OGT) silencing suppresses vascular calcification in chronic kidney disease (CKD) by reducing YAP and enhancing autophagy. This highlights OGT as a potential therapeutic target for preventing vascular calcification in CKD patients.

Area of Science:

  • Cardiovascular Biology
  • Nephrology
  • Cellular Metabolism

Background:

  • Pathological vascular calcification (VC) is a significant risk factor for cardiovascular mortality, particularly prevalent in chronic kidney disease (CKD).
  • Autophagy plays a protective role against high phosphate-induced VC.
  • The role of O-GlcNAc transferase (OGT) in mediating autophagy and VC in CKD remains to be fully elucidated.

Purpose of the Study:

  • To investigate the effect of O-GlcNAc transferase (OGT) on high phosphate-induced vascular calcification (VC) in chronic kidney disease (CKD).
  • To explore the role of OGT in mediating autophagy during high phosphate-induced VC.
  • To determine the interaction between OGT and Yes-associated protein (YAP) in the context of VC.

Main Methods:

  • Utilized a rat model of CKD induced by 5/6 nephrectomy and high phosphate diet to study VC.
  • Induced VSMC calcification in vitro using high phosphate treatment.
  • Performed loss-of-function experiments for OGT, co-immunoprecipitation, and GST pull-down assays to assess OGT-YAP interactions.
  • Measured autophagy markers, calcium deposition, and calcium content in response to altered OGT and YAP expression.

Main Results:

  • OGT expression was upregulated in high phosphate-induced VC models (in vitro and in vivo).
  • OGT silencing suppressed high phosphate-induced VC in rat aortas and VSMCs.
  • OGT enhanced YAP stability via glycosylation; overexpressing YAP reduced autophagy.
  • OGT accelerated high phosphate-induced VC by inhibiting autophagy through YAP upregulation.

Conclusions:

  • OGT silencing downregulates YAP, leading to autophagy activation and suppression of high phosphate-induced VC.
  • OGT inhibition presents a promising therapeutic strategy for preventing vascular calcification in CKD.
  • The OGT-YAP-autophagy pathway is a critical mechanism in high phosphate-induced VC in CKD.

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.6K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
251
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.6K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
434
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
683
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.5K